FHLC holdings
Fidelity MSCI Health Care Index ETF
Positions
337 stored of 337 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 301 | Arbutus Biopharma Corp | CA03879J1003 | 03879J100 | 0.009% | $288K | Equity (common) | Corporate | Canada | USD |
| 302 | LB Pharmaceuticals Inc | US50180M1080 | 50180M108 | 0.009% | $287K | Equity (common) | Corporate | United States | USD |
| 303 | Annexon Inc | US03589W1027 | 03589W102 | 0.009% | $287K | Equity (common) | Corporate | United States | USD |
| 304 | Olema Pharmaceuticals Inc | US68062P1066 | 68062P106 | 0.009% | $285K | Equity (common) | Corporate | United States | USD |
| 305 | Pulse Biosciences Inc | US74587B1017 | 74587B101 | 0.009% | $284K | Equity (common) | Corporate | United States | USD |
| 306 | Inhibrx Biosciences Inc | US45720N1037 | 45720N103 | 0.009% | $281K | Equity (common) | Corporate | United States | USD |
| 307 | Janux Therapeutics Inc | US47103J1051 | 47103J105 | 0.008% | $276K | Equity (common) | Corporate | United States | USD |
| 308 | Tilray Brands Inc | US88688T2096 | 88688T209 | 0.008% | $260K | Equity (common) | Corporate | United States | USD |
| 309 | Kestra Medical Technologies Ltd | BMG524411052 | Not reported | 0.008% | $258K | Equity (common) | Corporate | Bermuda | USD |
| 310 | Sana Biotechnology Inc | US7995661045 | 799566104 | 0.008% | $251K | Equity (common) | Corporate | United States | USD |
| 311 | Savara Inc | US8051111016 | 805111101 | 0.007% | $239K | Equity (common) | Corporate | United States | USD |
| 312 | OPKO Health Inc | US68375N1037 | 68375N103 | 0.007% | $238K | Equity (common) | Corporate | United States | USD |
| 313 | CytomX Therapeutics Inc | US23284F1057 | 23284F105 | 0.007% | $237K | Equity (common) | Corporate | United States | USD |
| 314 | CorMedix Inc | US21900C3088 | 21900C308 | 0.007% | $237K | Equity (common) | Corporate | United States | USD |
| 315 | Phreesia Inc | US71944F1066 | 71944F106 | 0.007% | $232K | Equity (common) | Corporate | United States | USD |
| 316 | ORIC Pharmaceuticals Inc | US68622P1093 | 68622P109 | 0.007% | $228K | Equity (common) | Corporate | United States | USD |
| 317 | Arvinas Inc | US04335A1051 | 04335A105 | 0.006% | $207K | Equity (common) | Corporate | United States | USD |
| 318 | Phathom Pharmaceuticals Inc | US71722W1071 | 71722W107 | 0.006% | $198K | Equity (common) | Corporate | United States | USD |
| 319 | Septerna Inc | US81734D1046 | 81734D104 | 0.005% | $152K | Equity (common) | Corporate | United States | USD |
| 320 | Prime Medicine Inc | US74168J1016 | 74168J101 | 0.004% | $145K | Equity (common) | Corporate | United States | USD |
| 321 | Ginkgo Bioworks Holdings Inc | US37611X2099 | 37611X209 | 0.004% | $141K | Equity (common) | Corporate | United States | USD |
| 322 | GoodRx Holdings Inc | US38246G1085 | 38246G108 | 0.004% | $132K | Equity (common) | Corporate | United States | USD |
| 323 | ARS Pharmaceuticals Inc | US82835W1080 | 82835W108 | 0.003% | $115K | Equity (common) | Corporate | United States | USD |
| 324 | Embecta Corp | US29082K1051 | 29082K105 | 0.003% | $96K | Equity (common) | Corporate | United States | USD |
| 325 | Chicago Mercantile Exchange XAV HEALTH CARE SEP26 | Not reported | Not reported | 0.003% | $92K | Equity derivatives | Other | United States | USD |
| 326 | Capricor Therapeutics Inc | US14070B3096 | 14070B309 | 0.003% | $85K | Equity (common) | Corporate | United States | USD |
| 327 | Upstream Bio Inc | US91678A1079 | 91678A107 | 0.002% | $73K | Equity (common) | Corporate | United States | USD |
| 328 | Compass Therapeutics Inc | US20454B1044 | 20454B104 | 0.002% | $71K | Equity (common) | Corporate | United States | USD |
| 329 | Evommune Inc | US30054Y1073 | 30054Y107 | 0.002% | $58K | Equity (common) | Corporate | United States | USD |
| 330 | Chicago Mercantile Exchange E-MINI RUSS 2000 SEP26 | Not reported | Not reported | −<0.001% | -$10K | Equity derivatives | Other | United States | USD |
| 331 | CONTRA AKOUOS INC | US009CVR0361 | 009CVR036 | <0.001% | $2K | Equity (common) | Corporate | United States | USD |
| 332 | OMNIAB INC | US68218J2024 | 68218J202 | <0.001% | $1K | Equity (common) | Corporate | United States | USD |
| 333 | CONTRA HOLOGIC INCORPO | US436CVR0216 | 436CVR021 | <0.001% | $1K | Equity (common) | Corporate | United States | USD |
| 334 | OMNIAB INC | US68218J3014 | 68218J301 | <0.001% | $867 | Equity (common) | Corporate | United States | USD |
| 335 | CONTRA CHINOOK THERAPE | US169CVR0169 | 169CVR016 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |
| 336 | CONTRA AKERO THERAPEUT | US009CVR0445 | 009CVR044 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |
| 337 | CONTRA ARCELLX INC | US039CVR0142 | 039CVR014 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |